BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 30640571)

  • 1. A patent review of arginine methyltransferase inhibitors (2010-2018).
    Li X; Wang C; Jiang H; Luo C
    Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
    Hu H; Qian K; Ho MC; Zheng YG
    Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).
    Dong J; Duan J; Hui Z; Garrido C; Deng Z; Xie T; Ye XY
    Expert Opin Ther Pat; 2022 Dec; 32(12):1185-1205. PubMed ID: 36594709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
    Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
    Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
    Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
    Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.
    Smith E; Zhou W; Shindiapina P; Sif S; Li C; Baiocchi RA
    Expert Opin Ther Targets; 2018 Jun; 22(6):527-545. PubMed ID: 29781349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
    Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
    Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.
    Noto PB; Sikorski TW; Zappacosta F; Wagner CD; Montes de Oca R; Szapacs ME; Annan RS; Liu Y; McHugh CF; Mohammad HP; Piccoli SP; Creasy CL
    Sci Rep; 2020 Dec; 10(1):22155. PubMed ID: 33335114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
    Al-Hamashi AA; Diaz K; Huang R
    Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites.
    van Haren M; van Ufford LQ; Moret EE; Martin NI
    Org Biomol Chem; 2015 Jan; 13(2):549-60. PubMed ID: 25380215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidic transition state analogues as PRMT inhibitors.
    Zhang Y; van Haren MJ; Martin NI
    Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.
    Wang J; Chen L; Sinha SH; Liang Z; Chai H; Muniyan S; Chou YW; Yang C; Yan L; Feng Y; Li KK; Lin MF; Jiang H; Zheng YG; Luo C
    J Med Chem; 2012 Sep; 55(18):7978-87. PubMed ID: 22928876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.
    Tewary SK; Zheng YG; Ho MC
    Cell Mol Life Sci; 2019 Aug; 76(15):2917-2932. PubMed ID: 31123777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
    Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
    Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach.
    Bhattacharya D; Shi Ming Li A; Paul B; Ghosh Dastidar U; Santhakumar V; Sarkar D; Chau I; Li F; Ghosh T; Vedadi M; Talukdar A
    Eur J Med Chem; 2023 Nov; 260():115713. PubMed ID: 37597437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine methylation: the promise of a 'silver bullet' for brain tumours?
    Samuel SF; Barry A; Greenman J; Beltran-Alvarez P
    Amino Acids; 2021 Apr; 53(4):489-506. PubMed ID: 33404912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical probes for protein arginine methyltransferases.
    Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
    Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
    Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
    J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
    Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
    Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.